N. Scott Fine - Feb 28, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Executive Officer, Director
Signature
/s/ N. Scott Fine
Stock symbol
CYTH
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:32 PM
Previous filing
Feb 7, 2022
Next filing
Mar 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Options (Right to buy) Award $0 +74.9K $0.00 74.9K Feb 28, 2022 Common Stock 74.9K $3.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.